Why Won’t My Sinus Infection Go Away?

Dr. Franklyn Gergits, ENT

Short answer: A sinus infection that will not go away despite multiple antibiotic courses is almost never an antibiotic problem. It is a diagnostic problem. Either the wrong organism is being treated, the treatment is not reaching the infected sinus, a biofilm is protecting the bacteria from the antibiotic, or the underlying driver — anatomy, allergy, reflux, immune dysregulation — has never been identified and addressed. Until those questions are answered, the cycle will continue regardless of which antibiotic is prescribed next.

The Question Nobody Has Asked You Yet

When a patient comes to us after two, three, or four failed antibiotic courses, the first thing I ask is always the same: has anyone ever done a culture before prescribing those antibiotics? In almost every case, the answer is no. No culture was done. The antibiotic was chosen based on probability — the most likely organism for the most likely infection — and prescribed without any direct knowledge of what was actually present in the sinus.

That is prescribing in the dark. And when it fails, the next antibiotic is chosen the same way — another educated guess, slightly broader, still without a culture. Each course selects for more resistant organisms. Each failure leaves the sinus environment more difficult to treat than it was before. The infection does not go away because the treatment has never been matched to the actual cause.

Why Antibiotics Fail — The Three Most Common Reasons

In patients with a sinus infection that will not resolve, the failure almost always comes down to one of three things — and frequently a combination of all three.

The wrong organism. Standard antibiotic selection is based on the most common pathogens for acute sinusitis. But patients who have been through multiple antibiotic courses frequently harbor resistant organisms — bacteria that standard antibiotics cannot kill — or polymicrobial infections with organisms that require targeted therapy rather than broad-spectrum coverage. Without knowing what is present, treatment is always a guess.

Biofilm. Bacteria inside the sinuses can form biofilms — communities encased in a protective matrix that shields them from antibiotic penetration. A standard antibiotic course suppresses the surface bacteria but does not penetrate the biofilm. The bacteria survive, re-emerge when the antibiotic is stopped, and the infection appears to return. It never fully left. Our approach to biofilm includes the xylitol, Johnson’s baby shampoo, and manuka honey rinse combination — each component targets biofilm disruption through a different biological mechanism, based on the rationale of multi-mechanism disruption and emerging clinical data — combined with culture-directed antibiotic therapy when appropriate.

The upstream driver. A sinus infection that recurs despite appropriate antibiotic therapy is almost always being sustained by an upstream driver that has never been addressed. Allergy driving chronic mucosal inflammation. Anatomical obstruction preventing normal sinus drainage. Laryngopharyngeal reflux — pepsin from the stomach reaching the posterior nasal cavity and causing mucosal injury that creates the conditions for recurrent infection. Immune dysregulation. Until the driver is identified and treated, the sinus environment remains primed for infection regardless of what antibiotic is used.

What We Do Differently at SAWC

At the Sinus and Allergy Wellness Center of North Scottsdale, we do not prescribe antibiotics without a culture. When a patient presents with signs of bacterial sinusitis — particularly a patient who has already failed previous treatment — we perform nasal endoscopy, obtain a directed specimen from the affected sinus drainage pathway, and send it for molecular diagnostic testing through MicroGenDX. MicroGenDX uses next-generation DNA sequencing to identify organisms in the specimen — including organisms that standard cultures miss because they are difficult to grow, are present in low abundance, or are protected within a biofilm. Clinical interpretation of these results requires expertise to distinguish the organisms actually driving the infection from commensal bacteria that may be present without causing disease — and that is precisely what we do.

The result tells us exactly what we are treating. The antibiotic we prescribe — if one is indicated — is chosen based on the specific organism and its sensitivity profile, not a probability table. For selected patients with recalcitrant or post-surgical disease, antibiotic delivery can also be topical — added to the nasal rinse and delivered directly to the sinus mucosa — rather than relying entirely on systemic absorption that may not reach adequate concentrations inside the sinuses. This approach is most supported by the evidence in culture-directed cases involving difficult-to-treat organisms such as S. aureus.

When the Infection Points to a Structural Problem

Some sinus infections do not resolve because the sinus cannot drain. The ostiomeatal complex — the drainage pathway for the maxillary, anterior ethmoid, and frontal sinuses — can be narrowed or blocked by anatomical factors, mucosal swelling, or polyps in a way that traps mucus and creates the conditions for persistent infection regardless of what antibiotic is used.

In these patients, the CT scan tells the story. The anatomy is the problem. And the answer is not a broader antibiotic — it is opening the drainage pathway so the sinus can ventilate and drain the way it was designed to. Balloon sinuplasty, performed in our office in North Scottsdale under local anesthesia, opens those blocked pathways without tissue removal, without a hospital, and without general anesthesia. For patients who are candidates, it addresses the structural reason the infection keeps returning — and recurrence from the same source is uncommon once adequate drainage is restored.

Want to Understand More?

This post is part of the Why Sinus Treatments Fail — And What Starts Before Them series on the Airway & Sinus Wellness Review.

→ Why Antibiotics Keep Failing Your Sinus Infection

→ Why Do I Keep Getting Sinus Infections After Surgery?

→ What Is MicroGenDX — and Why Does It Change How We Treat Sinus Infections?

→ Does Balloon Sinuplasty Actually Work?

→ Airway & Sinus Wellness Review — Full Publication

This post is part of the Why Sinus Treatments Fail — And What Starts Before Them section of the Airway & Sinus Wellness Review.

References

1. Piccirillo JF, Payne SC, Rosenfeld RM, et al. Clinical Practice Guideline: Adult Sinusitis Update. Otolaryngology–Head and Neck Surgery. 2025. AAO-HNS Adult Sinusitis Update 2025

2. Chow AW, Benninger MS, Brook I, et al. IDSA Clinical Practice Guideline for Acute Bacterial Rhinosinusitis in Children and Adults. Clinical Infectious Diseases. 2012. idsociety.org

3. Karunasagar A, Jalastagi R, Naik A, Rai P. Detection of bacteria by 16S rRNA PCR and sequencing in culture-negative chronic rhinosinusitis. The Laryngoscope. 2018.

4. Cummings LA, Hoogestraat DR, Rassoulian-Barrett SL, et al. Comprehensive evaluation of complex polymicrobial specimens using next generation sequencing and standard microbiological culture. Scientific Reports. 2020.

5. Centers for Disease Control and Prevention. Antibiotic prescribing and use — sinus infection (sinusitis). CDC.gov

6. American Academy of Family Physicians. Acute rhinosinusitis in adults. AAFP.org

7. Pritt BS, Leber AL, Burnham CA, et al. IDSA/ASM Guideline for the Diagnosis of Infectious Diseases through Metagenomics and Next-Generation Sequencing. Clinical Infectious Diseases. 2024.

8. Aldajani A, et al. Association between gastroesophageal reflux disease and chronic rhinosinusitis: a systematic review and meta-analysis. International Forum of Allergy & Rhinology. 2024. CI 3.56 [2.25, 5.65]; 93% of CRS patients showed improvement on PPIs.

About the Author

Dr. Franklyn R. Gergits, MBA, DO, FAOCO is a Board-Certified Otolaryngologist and Fellowship-Trained Otolaryngic Allergist with a Clinical Focus in Rhinology and Airway Disorders and over 30 years of clinical experience. He is the founder of the Sinus & Allergy Wellness Center of North Scottsdale, where he performs in-office balloon sinuplasty, turbinate reduction, NEUROMARK® posterior nasal nerve ablation, and Eustachian tube dilation under local anesthesia. He performed the first balloon sinuplasty in Pennsylvania and holds dual Entellus Centers of Excellence certifications. Dr. Gergits is the originator of the Posterior Sinonasal Syndrome (PSS) hypothesis — a clinical framework identifying pepsin-mediated posterior nasal mucosal injury as an upstream driver of chronic rhinosinusitis. Preprint available at Preprints.org (DOI: 10.20944/preprints202603.0858.v1). ORCID: 0009-0000-4893-6332.

SinusAndAllergyWellnessCenter.com · 480-525-8999

This content is for educational purposes only and does not constitute medical advice. If you have a sinus infection that has not responded to multiple antibiotic courses, consult with a qualified otolaryngologist for a complete evaluation including culture-directed therapy.